期刊
ADVANCED HEALTHCARE MATERIALS
卷 8, 期 5, 页码 -出版社
WILEY
DOI: 10.1002/adhm.201801358
关键词
ADPKD; microRNA; MRI; nanoparticles; plasmid DNA
资金
- Ministry of Science and Technology, Taiwan [MOST 106-2113-M-034-003, MOST 104-2113-M-006-015-MY2, MOST 104-2923-M-034-001-MY3, MOST 103-2314-B-006-019, MOST 104-2314-B-006-056-MY3]
There is currently no cure for gene mutation-caused autosomal dominant polycystic kidney disease (ADPKD). Over half of patients with ADPKD eventually develop kidney failure, requiring dialysis or kidney transplantation. Current treatment modalities for ADPKD focus on reducing morbidity and mortality from renal and extrarenal complications of the disease. MicroRNA has been shown to be useful in treating ADPKD. This study combines anti-miR NA plasmids and iron oxide/alginate nanoparticles for conjugation with antikidney antibodies. These nanocomposites can specifically target renal tubular cells, providing a potential treatment for ADPKD. Magnetic resonance imaging and in vivo imaging system results show effective targeting of renal cells. Anti-miRNA plasmids released from the nanocomposites inhibit cell proliferation and cyst formation in the PKD cellular and animal models. The results suggest the novel combination of the anti-miRNA plasmids and nanomaterials provides potential clinical implications for ADPKD treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据